These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 1747063)

  • 1. Bioavailability of bismuth from 205Bi-labelled pharmaceutical oral Bi-preparations in rats.
    Dresow B; Nielsen P; Fischer R; Wendel J; Gabbe EE; Heinrich HC
    Arch Toxicol; 1991; 65(8):646-50. PubMed ID: 1747063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bismuth absorption from 205Bi-labelled pharmaceutical bismuth compounds used in the treatment of peptic ulcer disease.
    Dresow B; Fischer R; Gabbe EE; Wendel J; Heinrich HC
    Scand J Gastroenterol; 1992 Apr; 27(4):333-6. PubMed ID: 1589712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Absorption and renal elimination of bismuth from 6 different bismuth salts after a single dosage].
    Heckers H; Mannl MR; Muskat E; Stelz A; Bödeker RH
    Z Gastroenterol; 1994 Jul; 32(7):375-81. PubMed ID: 7975772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution of bismuth in the rat after oral dosing with ranitidine bismuth citrate and bismuth subcitrate.
    Canena J; Reis J; Pinto AS; Santos AM; Leitão J; Pinheiro T; Quina MG
    J Pharm Pharmacol; 1998 Mar; 50(3):279-83. PubMed ID: 9600719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative absorption of bismuth in Sprague-Dawley rats following oral administration of preparations containing bismuth sucrose octasulfate, bismuth subsalicylate, and bismuth subcitrate.
    Rao N; Brown PW; Yerino P; Chang J; Hwang KK
    Biopharm Drug Dispos; 1997 Jan; 18(1):1-8. PubMed ID: 9008264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A study relating to bioavailability and renal elimination of bismuth after oral administration of basic bismuth nitrate.
    Behrendt WA; Gröger C; Kuhn D; Schulz HU; Topfmeier P
    Int J Clin Pharmacol Ther Toxicol; 1991 Sep; 29(9):357-60. PubMed ID: 1937997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bismuth biokinetics and kidney histopathology after bismuth overdose in rats.
    Leussink BT; Slikkerveer A; Krauwinkel WJ; van der Voet GB; de Heer E; de Wolff FA; Bruijn JA
    Arch Toxicol; 2000 Sep; 74(7):349-55. PubMed ID: 11043489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 205Bi/206Bi cyclotron production from Pb-isotopes for absorption studies in humans.
    Fischer R; Wendel J; Dresow B; Bechtold V; Heinrich HC
    Appl Radiat Isot; 1993 Dec; 44(12):1467-72. PubMed ID: 8257965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absorption of bismuth from several bismuth compounds during in vivo perfusion of rat small intestine.
    Slikkerveer A; Helmich RB; van Der Voet GB; de Wolff FA
    J Pharm Sci; 1995 Apr; 84(4):512-5. PubMed ID: 7629747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of meals on resorption of bismuth from an oral bismuth gallate/bismuth nitrate preparation].
    Leonhardt H; Klotz U
    Med Klin (Munich); 1991 Apr; 86(4):194-7. PubMed ID: 2056984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue and subcellular distribution of bismuth radiotracer in the rat: considerations of cytotoxicity and microdosimetry for bismuth radiopharmaceuticals.
    Zidenberg-Cherr S; Parks NJ; Keen CL
    Radiat Res; 1987 Jul; 111(1):119-29. PubMed ID: 3602349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of some chelating agents on bismuth absorption in the rat.
    Allain P; Krari N; Chaleil D; Lagier G; Jouglard J
    Fundam Clin Pharmacol; 1991; 5(1):39-45. PubMed ID: 1648536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclotron production of no-carrier-added 206Bi (6.24 d) and 205Bi (15.31 d) as tracers for biological studies and for the development of alpha-emitting radiotherapeutic agents.
    Lagunas-Solar MC; Carvacho OF; Nagahara L; Mishra A; Parks NJ
    Int J Rad Appl Instrum A; 1987; 38(2):129-37. PubMed ID: 3032861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of bismuth and ranitidine following single doses of ranitidine bismuth citrate.
    Koch KM; Davis IM; Gooding AE; Yin Y
    Br J Clin Pharmacol; 1996 Aug; 42(2):201-5. PubMed ID: 8864318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absorption of bismuth from two bismuth compounds before and after healing of peptic ulcers.
    Hundal O; Bergseth M; Gharehnia B; Andersen KJ; Berstad A
    Hepatogastroenterology; 1999; 46(29):2882-6. PubMed ID: 10576366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of bismuth and ranitidine following multiple doses of ranitidine bismuth citrate.
    Koch KM; Kerr BM; Gooding AE; Davis IM
    Br J Clin Pharmacol; 1996 Aug; 42(2):207-11. PubMed ID: 8864319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Localization of bismuth radiotracer in rat kidney following exposure to bismuth.
    Zidenberg-Cherr S; Clegg MS; Parks NJ; Keen CL
    Biol Trace Elem Res; 1989 Mar; 19(3):185-94. PubMed ID: 2484386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effect of Helicobacter pylori eradication therapy on bismuth absorption of colloidal bismuth subcitrate].
    Zhang L; Zhang ST; Yu ZL; Shao Y
    Zhonghua Nei Ke Za Zhi; 2005 Apr; 44(4):272-5. PubMed ID: 15924641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastrointestinal and systemic uptake of bismuth in mice after oral exposure.
    Larsen A; Martiny N; Stoltenberg M; Danscher G; Rungby J
    Pharmacol Toxicol; 2003 Aug; 93(2):82-90. PubMed ID: 12899670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and pharmacokinetics: colloidal bismuth subcitrate.
    Benet LZ
    Scand J Gastroenterol Suppl; 1991; 185():29-35. PubMed ID: 1957122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.